The Malvern Diabetic Foot Conference

The Malvern Diabetic Foot Conference

Every two years, in May, we have the privilege of running the Malvern Diabetic Foot meeting. The 2024 conference last month was the 20th meeting since its inception in 1986, and over three days engaged physicians, surgeons, podiatrists, orthotists, nursing staff and...
AI in Healthcare – Dr Google will see you now

AI in Healthcare – Dr Google will see you now

‘One of the key tenets of At the Limits has been to provide medical education to the widest possible audience, irrespective of global location or wealth. It’s a way in which we can contribute to the democratisation of healthcare. And that’s something that will...
Obesity at the Limits

Obesity at the Limits

5 continents, 2 days, 1 global event     Our biggest new event for some years is now well into development and we’re pleased to announce that Obesity at the Limits will join our roster of meetings in 2025. We’ve started early as the initiative is something...
Seasons Greetings, Merry Christmas and a Happy New Year

Seasons Greetings, Merry Christmas and a Happy New Year

Two subjects this month, a quick revisit to the VPAS situation and our plans for 2024. VPAS … again The new VPAS scheme was agreed at the end of November, and although the ABPI and Pharma Industry publicly support the deal it’s difficult to realistically see it as the...
Kon’nichiwa! Japan!

Kon’nichiwa! Japan!

This is always a busy time for us at At the Limits, as next year’s meetings are planned and we begin to construct the programmes for multiple events across the globe. This year is no exception. Not only are we working on continuing events in cardiology,...
The reputation of the Pharma Industry

The reputation of the Pharma Industry

A couple of months ago I downloaded the results a survey detailing reputational insights into the global pharmaceutical industry and I’ve been meaning to highlight the results on the blog ever since. The report, produced by Caliber (https://www.groupcaliber.com/)...
The consequences of VPAS

The consequences of VPAS

Two interesting subjects this month: firstly the VPAS scheme and the affect it’s having on industries other than big pharma, and secondly the results of a new survey which assesses the corporate reputations of the Pharma industry as a whole. VPAS To cut a long story...
ChatGPT: idiot or genius? I might have the answer.

ChatGPT: idiot or genius? I might have the answer.

Everybody is doing it, so why shouldn’t I?   Half the students around the world are using ChatGPT to write their essays, and probably more than half of marketing professionals are using it to write their presentations (although in the interests of full...
Open Dialogue LATAM webcasts has launched

Open Dialogue LATAM webcasts has launched

The in-person At the Limits meetings take place throughout the year and across the globe. But to stay in more frequent contact with our professional medical community in 2023 we’re expanding our modes and frequency of contact. This starts on February 13th when we will...